WASHINGTON — Clinical trials that the National Institutes of Health funds often enroll fewer Black patients and other underrepresented racial groups than they plan to, according to a study of 30 NIH-funded trials sampled by the HHS Office of Inspector General.
Policymakers want to get researchers to enroll a racially representative sample of patients in clinical trials that test whether products work and are safe. But researchers often fail to do so.